cladribine
pharmaceutical drug
Facts
15 properties- Instance of
- type of chemical entity
- Has use
- medication
- Active ingredient in
- Litak
- Canonical SMILES
- C1C(C(OC1N2C=NC3=C2N=C(N=C3N)Cl)CO)O
- Chemical formula
- C₁₀H₁₂ClN₅O₃
- Defined daily dose
- 0.34 mg
- Isomeric SMILES
- NC1=NC(Cl)=NC2=C1N=CN2[C@H]3C[C@H](O)[C@@H](CO)O3
- Legal status (medicine)
- boxed warning
- LiverTox likelihood score
- LiverTox toxicity likelihood category E
- Mass
- 285.062867 Da
- Medical condition treated
- hairy cell leukemia, multiple sclerosis, chronic lymphocytic leukemia, lymphosarcoma, hairy cell leukemia (1995–present)
- NCI Thesaurus ID
- C1336
- Pregnancy category
- Australian pregnancy category D, US pregnancy category D
- Subject has role
- DNA polymerase inhibitors, antineoplastic, immunosuppressive drug, developmental toxicant (1996–present)
🏷️ Also known as
en Cladribina
en RWJ-26251
en Leustatin
en CldAdo
en Cladribinum
en Cladribine
en cladribine
en 2-CdA
en 2-Chloro-2'-deoxyadenosine
en 2-Chloro-2'-deoxy-beta-adenosine
en 2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine
en 2-chloro-Deoxyadenosine
en 2-Chlorodeoxyadenosine
en 2ClAdo
en (2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol
ar كلادريبين
cs 2-chlorodeoxyadenosin
de Litak
de Movectro
de Cladribin
🔖 Identifiers · 40
- OpenAlex ID
- C2779200787
- CA PROP 65 ID
- cladribine
- CAS Registry Number
- 4291-63-8
- ChEBI ID
- 567361
- ChEMBL ID
- CHEMBL1619
- ChemSpider ID
- 19105
- DSSTOX compound identifier
- DTXCID602828
- DSSTox substance ID
- DTXSID8022828
- DrugBank ID
- DB00242
- DrugCentral ID
- 667
- EC number
- 636-978-6
Show all 40 identifiers +28
- ECHA Substance Infocard ID
- 100.164.726
- Freebase ID
- /m/088fns
- Guide to Pharmacology Ligand ID
- 4799
- HSDB ID
- 7564
- Human Metabolome Database ID
- HMDB0014387
- InChIKey
- PTOAARAWEBMLNO-KVQBGUIXSA-N
- KEGG ID
- D01370
- LiverTox ID
- Cladribine
- MassBank accession ID
- MSBNK-LCSB-LU134301, MSBNK-LCSB-LU134303, MSBNK-LCSB-LU134305, MSBNK-LCSB-LU134351, MSBNK-LCSB-LU134352, MSBNK-LCSB-LU134353, MSBNK-LCSB-LU134304, MSBNK-LCSB-LU134306, MSBNK-LCSB-LU134356, MSBNK-LCSB-LU134302, MSBNK-LCSB-LU134355, MSBNK-LCSB-LU134354
- MeSH concept ID
- M0026332
- MeSH descriptor ID
- D017338
- MeSH tree code
- D03.633.100.759.590.138.300.200, D03.633.100.759.590.138.325.075, D13.570.230.229.075, D13.570.583.138.300.200, D13.570.583.138.325.075, D13.570.800.096.300.200
- Microsoft Academic ID (discontinued)
- 2779200787
- NDF-RT ID
- N0000148293
- NL CR AUT ID
- ph117294
- NSC number
- 105014
- PDB ligand ID
- CL9
- Probes And Drugs ID
- PD003181
- PubChem CID
- 20279
- Reaxys registry number
- 624220
- RxNorm CUI
- 44157
- SureChEMBL ID
- 3775
- UNII
- 47M74X9YT5
- UniChem compound ID
- 1310
- WikiProjectMed ID
- Cladribine
🔗 Connections
Medical condition treated 4
← Drug or therapy used for treatment 4
Subject has role 3
Has use 1
Legal status (medicine) 1
Press Enter · cited answer in seconds
0 sources
Summary
cladribine is a type of chemical entity[1]. cladribine is a type of (3R)-5-(6-amino-2-chloro-9-purinyl)-2-(hydroxymethyl)-3-oxolanol[2].
Key Facts
- Canonical SMILES: C1C(C(OC1N2C=NC3=C2N=C(N=C3N)Cl)CO)O[3]
- Chemical formula: C₁₀H₁₂ClN₅O₃[4]
- Has use: medication[5]
- NCI Thesaurus ID: C1336[6]
- Isomeric SMILES: NC1=NC(Cl)=NC2=C1N=CN2[C@H]3CC@HC@@HO3C@HC@@HO3">[7]
- Mass: 285.062867 dalton[8]
- Medical condition treated: hairy cell leukemia[9], multiple sclerosis[10], chronic lymphocytic leukemia[11], lymphosarcoma[12]
- Subject has role: DNA polymerase inhibitors[13], antineoplastic[14], immunosuppressive drug[15], developmental toxicant[16]
- Pregnancy category: Australian pregnancy category D[17], US pregnancy category D[18]
- Legal status (medicine): boxed warning[19]
- Active ingredient in: Litak[20]
- Defined daily dose: 0.34 milligram[21]
- LiverTox likelihood score: LiverTox toxicity likelihood category E[22]